Completed
Dose Escalation Study Investigating Everolimus and Dovitinib in Metastatic Clear Cell Renal Cancer
NCT01714765
- Conditions
- Metastatic Clear Cell Renal Cancer
- Locations
-
- Barts Health NHS Trust London, United Kingdom